FDA recall Z-1758-2026

Product

Burlington Medical, BAT (Breast, Axilla and Thyroid) Coverage.

Reason for recall

Potential for attenuation degradation over time, decreasing the lifespan.

Distribution

Worldwide distribution. Nationwide distribution in the US and international distribution to Canada, Australia, Bangladesh, Chile, Hong Kong, India, Mexico, Malaysia, Panama, Singapore, Thailand, Taiwan, Uruguay, and Vietnam.

Key facts

Status

Ongoing

Initiation date

2026-02-11

Report date

2026-04-08

Voluntary/Mandated

Voluntary: Firm initiated

Location

Newport News, VA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1758-2026